Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial)

Previous studies among patients with atrial fibrillation showed that a history of heart failure (HF) could negatively impact anticoagulation quality, as measured by the average time in therapeutic range (TTR). Whether additional markers of HF severity are associated with TTR has not been investigate...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Cardiol
Main Authors: Lee, Tetz C., Qian, Min, Lip, Gregory Y.H., Di Tullio, Marco R., Graham, Susan, Mann, Douglas L., Nakanishi, Koki, Teerlink, John R., Freudenberger, Ronald S., Sacco, Ralph L., Mohr, J.P., Labovitz, Arthur J., Ponikowski, Piotr, Lok, Dirk J., Estol, Conrado, Anker, Stefan D., Pullicino, Patrick M, Buchsbaum, Richard, Levin, Bruce, Thompson, John L.P., Homma, Shunichi, Ye, Siqin
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6151139/
https://ncbi.nlm.nih.gov/pubmed/30037426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2018.05.024
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki